Goldenberg DM - Search Results

1

177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.

Michel RB, Andrews PM, Rosario AV, Goldenberg DM, Mattes MJ. Michel RB, et al. Among authors: goldenberg dm. Nucl Med Biol. 2005 Apr;32(3):269-78. doi: 10.1016/j.nucmedbio.2005.01.003. Nucl Med Biol. 2005. PMID: 15820762

2

Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74.

Michel RB, Rosario AV, Brechbiel MW, Jackson TJ, Goldenberg DM, Mattes MJ. Michel RB, et al. Among authors: goldenberg dm. Nucl Med Biol. 2003 Oct;30(7):715-23. doi: 10.1016/s0969-8051(03)00082-9. Nucl Med Biol. 2003. PMID: 14499329

3

Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.

Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ. Michel RB, et al. Among authors: goldenberg dm. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):777-86. Clin Cancer Res. 2005. PMID: 15701868

4

Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.

Govindan SV, Michel RB, Griffiths GL, Goldenberg DM, Mattes MJ. Govindan SV, et al. Among authors: goldenberg dm. Nucl Med Biol. 2005 Jul;32(5):513-9. doi: 10.1016/j.nucmedbio.2005.04.009. Nucl Med Biol. 2005. PMID: 15982582

5

Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons.

Mattes MJ, Goldenberg DM. Mattes MJ, et al. Among authors: goldenberg dm. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1249-58. doi: 10.1007/s00259-008-0731-3. Epub 2008 Feb 12. Eur J Nucl Med Mol Imaging. 2008. PMID: 18265976

6

Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo.

Stein R, Goldenberg DM, Ong GL, Thorpe SR, Mattes MJ. Stein R, et al. Among authors: goldenberg dm. J Nucl Med. 1997 Sep;38(9):1392-400. J Nucl Med. 1997. PMID: 9293796 Free article.

7

Improved iodine radiolabels for monoclonal antibody therapy.

Stein R, Govindan SV, Mattes MJ, Chen S, Reed L, Newsome G, McBride BJ, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Cancer Res. 2003 Jan 1;63(1):111-8. Cancer Res. 2003. PMID: 12517786

8

Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.

Stein R, Qu Z, Chen S, Rosario A, Shi V, Hayes M, Horak ID, Hansen HJ, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Clin Cancer Res. 2004 Apr 15;10(8):2868-78. doi: 10.1158/1078-0432.ccr-03-0493. Clin Cancer Res. 2004. PMID: 15102696

9

Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.

Stein R, Qu Z, Cardillo TM, Chen S, Rosario A, Horak ID, Hansen HJ, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Blood. 2004 Dec 1;104(12):3705-11. doi: 10.1182/blood-2004-03-0890. Epub 2004 Aug 5. Blood. 2004. PMID: 15297317 Free article.

10

CD74: a new candidate target for the immunotherapy of B-cell neoplasms.

Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. Stein R, et al. Among authors: goldenberg dm. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5556s-5563s. doi: 10.1158/1078-0432.CCR-07-1167. Clin Cancer Res. 2007. PMID: 17875789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

749 results

Search Page